News & Events
Veravas launched in 2017 with a mission that went far beyond just selling technology or building products. We want to impact healthcare, raising the bar for diagnostic accuracy, efficacy, and the scope of what can be tested.
Filter: News > Events > Webinars >
The FDA Warns that Biotin Interferes with Troponin Lab Tests
Today, the FDA issued an updated warning of biotin interference with certain laboratory tests. The FDA remains concerned about certain laboratory tests that have not addressed the risk of biotin interference. For example, the FDA has continued to receive adverse events reports indicating biotin interference caused falsely low troponin results.
November 5th - Today, the FDA issued an updated warning of biotin interference with certain laboratory tests. The FDA remains concerned about certain laboratory tests that have not addressed the risk of biotin interference. For example, the FDA has continued to receive adverse events reports indicating biotin interference caused falsely low troponin results.